We are live on ! Find out more
NERV icon

Minerva Neurosciences

67 hedge funds and large institutions have $343M invested in Minerva Neurosciences in 2016 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 33 increasing their positions, 10 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

230% more repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 10

53% more capital invested

Capital invested by funds: $225M → $343M (+$118M)

40% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 10

6% more funds holding

Funds holding: 6367 (+4)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

Holders
67
Holders Change
+4
Holders Change %
+6.35%
% of All Funds
1.79%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
14
Increased
33
Reduced
10
Closed
10
Calls
$97K
Puts
Net Calls
+$97K
Net Calls Change
+$97K
Name Holding Trade Value Shares
Change
Change in
Stake
EA
26
Emerald Acquisition
Washington
$1.02M +$117K +1,210 +15%
Handelsbanken Fonder
27
Handelsbanken Fonder
Sweden
$988K +$243K +2,500 +40%
Bank of New York Mellon
28
Bank of New York Mellon
New York
$835K +$97.4K +1,004 +16%
AllianceBernstein
29
AllianceBernstein
Tennessee
$826K
California State Teachers Retirement System (CalSTRS)
30
California State Teachers Retirement System (CalSTRS)
California
$567K +$80.1K +825 +20%
M&T Bank
31
M&T Bank
New York
$523K +$141K +1,451 +46%
Jacobs Levy Equity Management
32
Jacobs Levy Equity Management
New Jersey
$510K -$14.6K -150 -3%
DCM
33
DAFNA Capital Management
California
$467K -$570K -5,875 -59%
TA
34
Teachers Advisors
New York
$411K +$37.8K +390 +12%
AQR Capital Management
35
AQR Capital Management
Connecticut
$393K +$338K +3,481 New
TD Asset Management
36
TD Asset Management
Ontario, Canada
$392K +$337K +3,472 New
CAM
37
ClariVest Asset Management
California
$376K +$6.02K +62 +2%
VEA
38
Virtus ETF Advisers
New York
$362K
Charles Schwab
39
Charles Schwab
California
$353K
SCM
40
Sterling Capital Management
North Carolina
$322K +$112K +1,153 +68%
SSA
41
Schonfeld Strategic Advisors
New York
$289K +$248K +2,560 New
Morgan Stanley
42
Morgan Stanley
New York
$265K -$18.7K -193 -8%
AL
43
Airain Ltd
Guernsey
$244K +$210K +2,161 New
New York State Common Retirement Fund
44
New York State Common Retirement Fund
New York
$244K +$210K +2,163 New
RhumbLine Advisers
45
RhumbLine Advisers
Massachusetts
$243K +$19.1K +197 +10%
MLICM
46
Metropolitan Life Insurance Company (MetLife)
New York
$227K +$196K +2,015 New
PPA
47
Parametric Portfolio Associates
Washington
$200K +$44.6K +460 +35%
Manulife (Manufacturers Life Insurance)
48
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$194K +$14.7K +151 +10%
CS
49
Credit Suisse
Switzerland
$190K +$163K +1,684 New
NFA
50
Nationwide Fund Advisors
Ohio
$162K +$12.9K +133 +10%

NERV Hedge Fund Activity: Q3 2016 in Review

67 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Minerva Neurosciences (NERV) for Q3 2016, worth a combined $343M — up 53% from $225M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new NERV positions and 10 closed out — a net gain of 4 holders — while 33 added to existing stakes and 10 trimmed.

The largest buyer was T. Rowe Price Associates, opening a new position worth an estimated $7.77M. The largest seller was Baker Bros. Advisors, cutting an estimated $3.03M.

  • 67 institutional investors held Minerva Neurosciences (NERV) as of Q3 2016, up from 63 in Q2 2016.
  • Funds reported $343M of Minerva Neurosciences stock for Q3 2016, up 53% quarter-over-quarter.
  • 14 funds opened new Minerva Neurosciences positions in Q3 2016 and 10 closed out, a net change of +4 holders.
  • The largest Minerva Neurosciences buyer in Q3 2016 was T. Rowe Price Associates, an estimated $7.77M added.
  • The largest Minerva Neurosciences seller in Q3 2016 was Baker Bros. Advisors, an estimated $3.03M sold.

Based on aggregated 13F filings for Q3 2016.